This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Prolynx LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Samuel J. Pfaff and His Patent Work.
Introduction
Samuel J. Pfaff is an inventor associated with San Francisco, California. His recorded patent work concerns a cytokine-conjugate technology intended for slow release.
Latest Patents
Pfaff is credited with 1 patent: “Slow-Release Cytokine Conjugates.” The patent describes an approach to conjugating cytokines for gradual release.
Career Highlights
Pfaff has been associated with Prolynx LLC and Silver Creek Pharmaceuticals, Inc. His patent reflects work in pharmaceutical and biotechnology innovation.
Collaborations
His listed coworkers include John A. Hangasky III and Daniel V. Santi, who are also associated with the biotechnology and pharmaceutical research community.
Conclusion
Samuel J. Pfaff’s recorded invention, “Slow-Release Cytokine Conjugates,” represents his contribution to research focused on controlled cytokine delivery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile